Concepedia

The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody

Shuhei Maruyama, Daiki Wada, Shuji Kanayama, Haruka Shimazu, Yumiko Miyano, Akira Inoue, Masami Kashihara, Kazuyuki Okuda, Fukuki Saito, Yasushi Nakamori,

BMC Infectious Diseases · 2024 · 12 citations · 28 references

Open access

References

28

An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies

Laura A. VanBlargan, John M. Errico, Peter Halfmann et al. · Nature Medicine · 2022 · 758 citations · Full text

Vaccination, Therapeutic Monoclonal Antibodies, Immunology +7

Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients

Baoqing Sun, Ying Feng, Xiaoneng Mo et al. · Emerging Microbes & Infections · 2020 · 534 citations · Full text

Serum Antibody Testing, Long Covid, Sars-cov-2 Specific Igm +14

Multiple pathways for SARS-CoV-2 resistance to nirmatrelvir

Sho Iketani, Hiroshi Mohri, Bruce Culbertson et al. · Nature · 2022 · 437 citations · Full text

Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant

New England Journal of Medicine · 2022 · 401 citations · Full text

Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2

New England Journal of Medicine · 2022 · 290 citations · Full text